MediciNova Inc expected to post a loss of 9 cents a share - Earnings Preview

Medicinova

08/11/2022 17:41

* MediciNova Inc  MNOV.OQ   MNOV.O  is expected to show a
fall in
quarterly revenue when it reports  results on November 10
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for MediciNova Inc is
for a
loss of 9 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for MediciNova
Inc is
$6​, above​ its last closing price of $2.18. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.09       -0.09      -0.08     Beat    7.7
 Mar. 31 2022              -0.09                        
 Dec. 31 2021  -0.09       -0.09      -0.04     Beat    57.1​
 Sep. 30 2021              -0.09      -0.07     Beat    22.2
 ​​Jun.        -0.09       -0.09      -0.09     Met     -3.8
 30 2021                                                
 Mar. 31 2021  -0.08       -0.08      0.00      Beat    100​
 Dec. 31 2020              -0.09      -0.06     Beat    36.7
 Sep. 30 2020  -0.11       -0.12      -0.08     Beat    33.3
 This summary was machine generated November 8 at 17:41 GMT.  All
figures in US dollars  unless otherwise stated